Zobrazeno 1 - 10
of 162
pro vyhledávání: '"LANIYATI HAMIJOYO"'
Publikováno v:
Indonesian Biomedical Journal, Vol 16, Iss 5, Pp 397-410 (2024)
BACKGROUND: Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by inflammation. The pathogenesis of SLE involves key proteins, including B cell-activating factor (BAFF) and the ubiquitin enzyme A20, both serving as negative reg
Externí odkaz:
https://doaj.org/article/5b4aac3ee79a440daac87ea2dad64d1b
Autor:
Ricardo Azêdo de Luca Montes, Molla Huq, Timothy Godfrey, Shereen Oon, Alicia Calderone, Rangi Kandane-Rathnayake, Worawit Louthrenoo, Shue-Fen Luo, Yeong-Jian Jan Wu, Vera Golder, Aisha Lateef, Sandra V. Navarra, Leonid Zamora, Laniyati Hamijoyo, Sargunan Sockalingam, Yuan An, Zhanguo Li, Yasuhiro Katsumata, Masayoshi Harigai, Madelynn Chan, Fiona Goldblatt, Sean O’Neill, Chak Sing Lau, Jiacai Cho, Alberta Hoi, Chetan S. Karyekar, Eric F. Morand, Mandana Nikpour
Publikováno v:
Advances in Rheumatology, Vol 64, Iss 1, Pp 1-10 (2024)
Abstract Background This study examines the association of standard-of-care systemic lupus erythematosus (SLE) medications with key outcomes such as low disease activity attainment, flares, damage accrual, and steroid-sparing, for which there is curr
Externí odkaz:
https://doaj.org/article/f7e9c10f10e44e0fa19fee087d51bc04
Autor:
Tsutomu Takeuchi, Yoshiya Tanaka, Rangi Kandane-Rathnayake, Ning Li, Sang-Cheol Bae, Zhanguo Li, Shereen Oon, Vera Golder, Mandana Nikpour, Masayoshi Harigai, Yi-Hsing Chen, Zhuoli Zhang, Eric Morand, Chak Sing Lau, Worawit Louthrenoo, Alberta Hoi, Sandra Navarra, Sean O’Neill, Shue-Fen Luo, Jun Kikuchi, Yanjie Hao, Yasuhiro Katsumata, Aisha Lateef, Laniyati Hamijoyo, Sargunan Sockalingam, Nicola Tugnet, Madelynn Chan, Jiacai Cho, Leonid Zamora, Fiona Goldblatt, Kristine Ng, Yeong-Jian Jan Wu, Dylan Hansen, B M D B Basnayake
Publikováno v:
Lupus Science and Medicine, Vol 11, Iss 2 (2024)
Objectives The lupus low disease activity state (LLDAS) allows for certain clinical and/or serological activity of SLE, provided overall disease activity does not exceed predefined cut-offs. This study aimed to evaluate the outcomes of patients who a
Externí odkaz:
https://doaj.org/article/cb33790523424640ae42812b39be75b7
Publikováno v:
Acta Medica Indonesiana, Vol 56, Iss 3 (2024)
A 62-year-old active career woman came to the clinic with a chief complaint of left heel pain for 7 months without numbness. She had previously sought consultation at several clinics and was prescribed oral nonsteroidal anti-inflammatory and opioid a
Externí odkaz:
https://doaj.org/article/bf893785af0245738d110cf0401fd248
Publikováno v:
Journal of Clinical Rheumatology and Immunology, Vol 23, Iss 02, Pp 68-73 (2023)
Patient empowerment in lupus is a process wherein patients actively participate in decision-making with healthcare professionals and take responsibility for their own condition. In order to effectively be involved in their medical care and achieve th
Externí odkaz:
https://doaj.org/article/686e7d84e94841388ceb3c6e6667eb5a
Autor:
Indra Wijaya, M Lucky Nurdiansyah Prameswara, Dimmy Prasetya, Laniyati Hamijoyo, Bachti Alisjahbana, Andri Reza Rahmadi
Publikováno v:
Acta Medica Indonesiana, Vol 56, Iss 1 (2024)
Background: Osteoporosis is a major problem in transfusion-dependent thalassemia patients (TDT) patients. Osteoprotegerin (OPG) is one of several bone markers that are closely associated with osteoporosis in TDT patients. OPG is a glycoprotein that f
Externí odkaz:
https://doaj.org/article/b8324981630c443088cc3cbffc778603
Autor:
Marita Restie Tiara, Chrisan Bimo Prayuda, Tara Titian Maulidya, Hofiya Djauhari, Dadang Suhendar, Rudi Wisaksana, Laniyati Hamijoyo, Rudi Supriyadi, Agnes Rengga Indrati, Bachti Alisjahbana
Publikováno v:
Vaccines, Vol 12, Iss 5, p 558 (2024)
The presence of the anti-SARS-CoV-2-RBD antibody (anti-RBD) prevents severe COVID-19. We aimed to determine the accuracy of a point-of-care anti-RBD testing implemented in persons living with HIV (PLWH), systemic lupus erythematosus (SLE), and chroni
Externí odkaz:
https://doaj.org/article/89ed58597d764fdb94e72b8b0170e958
Publikováno v:
Acta Medica Indonesiana, Vol 55, Iss 3 (2023)
A 6-month cyclophosphamide induction therapy followed by maintenance therapy every three months is the first-line treatment for Class III, IV, and V lupus nephritis. Among the 139 single nucleotide polymorphisms (SNPs) associated with cyclophosphamid
Externí odkaz:
https://doaj.org/article/b89ac5378d44425f82ddfe8ef36b7ae6
Autor:
Tsutomu Takeuchi, Yoshiya Tanaka, Rangi Kandane-Rathnayake, Sang-Cheol Bae, Zhanguo Li, Shereen Oon, Vera Golder, Mandana Nikpour, Masayoshi Harigai, Yi-Hsing Chen, Zhuoli Zhang, Eric Morand, Chak Sing Lau, Sunil Kumar, Alberta Hoi, Sandra Navarra, Sean O’Neill, Michael Tee, Jun Kikuchi, Yanjie Hao, Shue Fen Luo, Yasuhiro Katsumata, Aisha Lateef, Laniyati Hamijoyo, Sargunan Sockalingam, Nicola Tugnet, Madelynn Chan, Jiacai Cho, Cherica Tee, Leonid Zamora, BMDB Basnayake, Fiona Goldblatt, Naoaki Ohkubo, Kristine (Pek Ling) Ng, Louthrenoo Worawit, Yeong-Jian Jan Wu, Annie Hui Nee Law
Publikováno v:
Lupus Science and Medicine, Vol 10, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/bdbf55b194f6481798620e562a199f17
Publikováno v:
Lupus Science and Medicine, Vol 10, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/cee05bb9f5cc4b61b659c3d4fe9aa593